Roxadustat CKD Doubts Fanned By FibroGen Data Blunder

Focus Moves To 15 July Cardio-Renal FDA Adcomm

 
• By Sten Stovall
  
CKD
FibroGen’s ‘Post Hoc’ Data Revelations Magnify Roxadustat Uncertainty • Source: Shutterstock

More from Clinical Trials

More from R&D